Summary

Dr. Rogerio Lilenbaum is an oncologist with four decades of experience treating cancer patients. He earned his medical degree from Universidade Federal Do Rio De Janeiro (Ufrj) Faculdade De Medicina and completed his residency at Barnes Jewish Hospital. Dr. Lilenbaum speaks English and brings extensive expertise to his oncology practice.

Dr. Lilenbaum is affiliated with Yale New Haven Hospital and practices in Jupiter, Florida. He treats patients with conditions such as benign breast cysts and chronic sinusitis. His clinical skills include performing scintimammography and breast ultrasound procedures to help diagnose and monitor patient conditions. Patients rate Dr. Lilenbaum 4.4 out of 5 stars on average.

Overview based on verified provider data

Quick Facts

  • 4.4
  • 40 years of experience
  • 3 insurance plans accepted
  • speaks English
  • Barnes Jewish Hospital
  • 4 written reviews
  • 1 specialty
  • 7 areas of expertise
  • 1 board certification
  • 1 hospital affiliation
  • 2 office locations
  • Male

Office Locations

Dr. Rogerio Cezar Lilenbaum has 2 locations

Jupiter Medical Center Inc

1210 S Old Dixie HwyJupiter, FL 33458

Dr. Rogerio Cezar Lilenbaum

2946 E Banner Gateway DrGilbert, AZ 85234
Mon7:00 am - 5:00 pm
Tue7:00 am - 5:00 pm
Wed7:00 am - 5:00 pm
Thu7:00 am - 5:00 pm
Fri7:00 am - 5:00 pm
SatClosed
SunClosed

Compare with Similar Doctors

Dr. Rogerio Cezar Lilenbaum, MD
Desiree Eugenie Simon
Anna Manasherov
April Nadine Roemer
Dr. Rogerio Cezar Lilenbaum, MDDesiree Eugenie SimonAnna ManasherovApril Nadine Roemer
OncologyNurse PractitionerNurse PractitionerNurse Practitioner
Accepts New Patients Accepts New Patients
4.4 
40 Years of Experience
No Virtual Visit Option No Virtual Visit Option No Virtual Visit Option No Virtual Visit Option
Speaks English
Jupiter , FLDavie , FLPalm Beach Gardens , FLLoxahatchee , FL
Med School: Universidade Federal Do Rio De Janeiro (Ufrj) Faculdade De Medicina
Current Profile
View Profile View Profile View Profile

Insurance Plans Accepted by Dr. Rogerio Cezar Lilenbaum

  • Blue Cross Blue Shield
  • Devoted Health
  • UnitedHealthcare

Medical Specialties

Dr. Rogerio Cezar Lilenbaum has the following specialty

Specialty Expertise

Dr. Rogerio Cezar Lilenbaum has the following 7 areas of expertise

  • Cancer
  • Cancerous Tumor
  • Chemotherapy
  • Epidemiology
  • Lung Cancer
  • Lung Cancer (Small Cell Carcinoma)
  • Metastasis

Certifications, License, & Education

40 Years Experience

EDUCATION & TRAINING

Residency

Barnes Jewish Hospital

Medical School

Universidade Federal Do Rio De Janeiro (Ufrj) Faculdade De MedicinaGraduated in 1986

Similar doctors

Frequently Asked Questions

How can I make an appointment with Dr. Rogerio Lilenbaum?
You can find contact information for Dr. Rogerio Lilenbaum here on Vitals.
Which hospitals is Dr. Rogerio Lilenbaum affiliated with?
Dr. Rogerio Lilenbaum is affiliated with Yale New Haven Hospital.
Does Dr. Rogerio Lilenbaum accept my insurance?
You can see the insurance plans that Dr. Rogerio Lilenbaum accepts on their Vitals profile.
What languages does Dr. Rogerio Lilenbaum speak?
Dr. Rogerio Lilenbaum speaks English.
Is Dr. Rogerio Lilenbaum accepting new patients?
Dr. Rogerio Lilenbaum has not indicated that they accept new patients. Contact their office through their Vitals profile to check for availability.

Ensuring Data Transparency and Trust: A Guide to Vitals Doctor Listings and Reviews

Our provider data is gathered directly from physicians and publicly available databases. Providers who verify their profiles gain the ability to update information, offering additional details about their specialties,education, treated conditions, performed procedures, and accepted insurances.

Reviews on Vitals are submitted by users only. Recognizing the valuable insights these reviews offer into a doctor's reputation, we maintain internal policies and protocols to ensure the quality and accuracy of all reviews. Importantly, providers cannot delete or alter reviews independently. Reviews can only be deleted or changed following an internal assessment by our customer service team.

Your feedback is highly valued and we encourage you to contact our support team should you encounter any issues.